Cargando…

Treatment options for second-stage gambiense human African trypanosomiasis

Treatment of second-stage gambiense human African trypanosomiasis relied on toxic arsenic-based derivatives for over 50 years. The availability and subsequent use of eflornithine, initially in monotherapy and more recently in combination with nifurtimox (NECT), has drastically improved the prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eperon, Gilles, Balasegaram, Manica, Potet, Julien, Mowbray, Charles, Valverde, Olaf, Chappuis, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743611/ https://www.ncbi.nlm.nih.gov/pubmed/25204360 http://dx.doi.org/10.1586/14787210.2014.959496

Ejemplares similares

Early Prediction of Treatment Efficacy in Second-Stage Gambiense Human African Trypanosomiasis
por: Priotto, Gerardo, et al.
Publicado: (2012)

Updated estimate of the duration of the meningo-encephalitic stage in gambiense human African trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2015)

Accuracy of Five Algorithms to Diagnose Gambiense Human African Trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2011)

The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2018)

African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005)

Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan
por: Checchi, Francesco, et al.
Publicado: (2012)

Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022)

Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency?
por: Hasker, Epco, et al.
Publicado: (2012)

Is vector control needed to eliminate gambiense human African trypanosomiasis?
por: Solano, Philippe, et al.
Publicado: (2013)

Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis
por: Simarro, Pere P., et al.
Publicado: (2015)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

Syndromic Algorithms for Detection of Gambiense Human African Trypanosomiasis in South Sudan
por: Palmer, Jennifer J., et al.
Publicado: (2013)

First WHO Meeting of Stakeholders on Elimination of Gambiense Human African Trypanosomiasis
por: Holmes, Peter
Publicado: (2014)

Serological tests for gambiense human African trypanosomiasis detect antibodies in cattle
por: Matovu, Enock, et al.
Publicado: (2017)

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis
por: Barrett, Michael P.
Publicado: (2018)

The impact of vector migration on the effectiveness of strategies to control gambiense human African trypanosomiasis
por: Ndeffo-Mbah, Martial L., et al.
Publicado: (2019)

Extravascular Dermal Trypanosomes in Suspected and Confirmed Cases of gambiense Human African Trypanosomiasis
por: Camara, Mariame, et al.
Publicado: (2020)

Cardiac Alterations in Human African Trypanosomiasis (T.b. gambiense) with Respect to the Disease Stage and Antiparasitic Treatment
por: Blum, Johannes A., et al.
Publicado: (2009)

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection
por: Ngay Lukusa, Ipos, et al.
Publicado: (2021)

The Genome Sequence of Trypanosoma brucei gambiense, Causative Agent of Chronic Human African Trypanosomiasis
por: Jackson, Andrew P., et al.
Publicado: (2010)

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo
por: Crump, Ronald E., et al.
Publicado: (2021)

Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad
por: Rock, Kat S., et al.
Publicado: (2022)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC
por: Crump, Ronald E., et al.
Publicado: (2022)

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
por: Kande Betu Ku Mesu, Victor, et al.
Publicado: (2021)

Gambiense Human African Trypanosomiasis and Immunological Memory: Effect on Phenotypic Lymphocyte Profiles and Humoral Immunity
por: Lejon, Veerle, et al.
Publicado: (2014)

Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis
por: Simarro, Pere P, et al.
Publicado: (2014)

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
por: Dama, Emilie, et al.
Publicado: (2019)

Human African Trypanosomiasis in Areas without Surveillance
por: Chappuis, François, et al.
Publicado: (2010)

Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda – Moving towards elimination
por: Wamboga, Charles, et al.
Publicado: (2017)

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study
por: Ngay Lukusa, Ipos, et al.
Publicado: (2022)

Unusual MRI Findings in African Trypanosoma brucei gambiense Trypanosomiasis: Dentate Nuclei and Hypothalamic Lesions
por: Boukobza, Monique, et al.
Publicado: (2020)

Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso
por: Compaoré, Charlie Franck Alfred, et al.
Publicado: (2022)

Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad
por: Antillon, Marina, et al.
Publicado: (2023)

Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d’Ivoire using an integrated approach
por: Kaba, Dramane, et al.
Publicado: (2023)

Chemotherapy for second‐stage human African trypanosomiasis: drugs in use
por: Lutje, Vittoria, et al.
Publicado: (2021)

Identifying Transmission Cycles at the Human-Animal Interface: The Role of Animal Reservoirs in Maintaining Gambiense Human African Trypanosomiasis
por: Funk, Sebastian, et al.
Publicado: (2013)

Estimates of the duration of the early and late stage of gambiense sleeping sickness
por: Checchi, Francesco, et al.
Publicado: (2008)

Molecular evidence of a Trypanosoma brucei gambiense sylvatic cycle in the human african trypanosomiasis foci of Equatorial Guinea
por: Cordon-Obras, Carlos, et al.
Publicado: (2015)

Development and implementation of a strategy for intensified screening for gambiense human African trypanosomiasis in Kongo Central province, DRC
por: Lumbala, Crispin, et al.
Publicado: (2020)

Insights from quantitative and mathematical modelling on the proposed 2030 goal for gambiense human African trypanosomiasis (gHAT)
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r0k7cu9q6q80u4kl01fek2iebq